Altman, George http://orcid.org/0000-0002-4184-2963
Ahuja, Janvi
Monrad, Joshua Teperowski
Dhaliwal, Gurpreet
Rogers-Smith, Charlie
Leech, Gavin
Snodin, Benedict
Sandbrink, Jonas B.
Finnveden, Lukas http://orcid.org/0000-0001-8548-5788
Norman, Alexander John
Oehm, Sebastian B. http://orcid.org/0000-0002-7099-0578
Sandkühler, Julia Fabienne
Kulveit, Jan
Flaxman, Seth
Gal, Yarin
Mishra, Swapnil http://orcid.org/0000-0002-8759-5902
Bhatt, Samir
Sharma, Mrinank
Mindermann, Sören
Brauner, Jan Markus http://orcid.org/0000-0002-1588-5724
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/T008784/1)
RCUK | Engineering and Physical Sciences Research Council (EP/V002910/1, EP/S024050/1, EP/S024050/1)
Academy of Medical Sciences (SBF004/1080)
Academy of Medical Royal Colleges (MR/R015600/1)
Imperial College Healthcare NHS Trust (RDA02)
Novo Nordisk (NNF20OC0059309)
Article History
Received: 13 October 2021
Accepted: 27 January 2022
First Online: 1 April 2022
Competing interests
: J. Kulveit has advised several governmental and nongovernmental entities about interventions against COVID-19. Y. Gal has received a research grant (studentship) from GlaxoSmithKline, outside of the submitted work. S. Bhatt sits on and advises the Scientific Pandemic Influenza Group on Modelling (SPI-M) a subgroup of the Scientific Advisory Group for Emergencies (SAGE). His work on this board is funded by the UKRI/MRC. The remaining authors declare no competing interests.